Document Detail


The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).
MedLine Citation:
PMID:  17191149     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Natural killer (NK) cell alloreactions against recipient cells in the setting of bone marrow transplantation have been associated with decreased rates of graft-versus-host disease (GVHD) and improved survival in transplant recipients with myeloid leukemia. These alloreactions are predicted by the absence of recipient HLA class I ligands for donor inhibitory killer Ig-like receptors (KIR). We hypothesized that donor NK cell alloreactions against recipient cells may affect the development of T and B-cell functions and incidence of GVHD in infants with severe combined immunodeficiency (SCID). Of the 156 patients with SCID who had received related bone marrow transplants without pretransplant chemotherapy or posttransplant GVHD prophylaxis, 137 patient-donor pairs were evaluated for the absence of recipient HLA class I ligands for donor inhibitory KIR. Analysis showed that the absence of a KIR ligand had no effect on the incidence or severity of GVHD (RR [corrected] = 0.95, p = 0.84), development of T-cell function (RR [corrected] = 1.05, p = 0.69), production of IgA (p = 0.46) or IgM (p = 0.33), or on 5-year survival (RR [corrected] = 1.21, p = 0.10). Further, in patients possessing native NK cells, the absence of KIR ligands in donors for recipient-inhibitory KIR did not alter transplantation outcomes. This study suggests that inhibitory KIR/HLA interactions do not play a significant role in bone marrow transplantation for SCID.
Authors:
M D Keller; D F Chen; S A Condron; N Liu; N L Reinsmoen; R H Buckley
Related Documents :
2190659 - A role of herpes virus serology for the development of acute graft-versus-host disease....
2199009 - An overview of bone marrow transplantation for chronic myeloid leukemia.
9645569 - Big bu/cy is associated with a favorable long-term outcome in patients allotransplanted...
10347989 - Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloabl...
12750699 - Higher doses of cd34+ peripheral blood stem cells are associated with increased mortali...
1536959 - Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutroph...
15518789 - Impact of positive pra on the results of abo-incompatible kidney transplantation.
22096039 - Aki associated with macroscopic glomerular hematuria: clinical and pathophysiologic con...
3043779 - Early function as the principal correlate of graft survival. a multivariate analysis of...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2006-12-27
Journal Detail:
Title:  Journal of clinical immunology     Volume:  27     ISSN:  0271-9142     ISO Abbreviation:  J. Clin. Immunol.     Publication Date:  2007 Jan 
Date Detail:
Created Date:  2007-02-08     Completed Date:  2007-05-08     Revised Date:  2008-01-31    
Medline Journal Info:
Nlm Unique ID:  8102137     Medline TA:  J Clin Immunol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  109-16     Citation Subset:  IM    
Affiliation:
Division of Pediatric Allergy and Immunology, Duke University Medical Center, Durham, North Carolina, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bone Marrow Transplantation / immunology*
Disease-Free Survival
Female
Follow-Up Studies
Graft vs Host Disease / immunology
Hematopoietic Stem Cell Transplantation*
Histocompatibility Antigens / immunology
Histocompatibility Testing
Humans
Infant
Infant, Newborn
Killer Cells, Natural / immunology*
Lymphocyte Depletion / methods
Male
Receptors, Immunologic / immunology*
Receptors, KIR
Retrospective Studies
Severe Combined Immunodeficiency / immunology*,  therapy*
Transplantation, Homologous
Treatment Outcome
Grant Support
ID/Acronym/Agency:
5R01-AI/HD042951-07/AI/NIAID NIH HHS
Chemical
Reg. No./Substance:
0/Histocompatibility Antigens; 0/Receptors, Immunologic; 0/Receptors, KIR
Comments/Corrections
Erratum In:
J Clin Immunol. 2007 Nov;27(6):659

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Social cognition and externalizing psychopathology: an investigation of the mediating role of langua...
Next Document:  Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry.